30 Day FDA and ICH Drug Development Regulations - Day 2 FDA Overview episode artwork

EPISODE · Jan 28, 2025 · 15 MIN

30 Day FDA and ICH Drug Development Regulations - Day 2 FDA Overview

from Cannabinoid and Psychedelic Pharmacology and Drug Development

In today’s episode, we continue our exploration into the intricate world of drug development, this time focusing on the pivotal role of the U.S. Food and Drug Administration (FDA). From preclinical research to post-market surveillance, we unpack how the FDA safeguards public health at every stage of a drug’s journey—from the lab to your medicine cabinet. Join us as we dive into: - The FDA’s mission and structure - Key regulatory pathways like INDs (Investigational New Drug Applications) and NDAs (New Drug Applications) - The agency's oversight of dietary supplements, cosmetics, and even food additives - The ongoing monitoring of drug safety through tools like PBRERs (Periodic Benefit-Risk Evaluation Reports) - How the FDA adapts to emerging technologies like artificial intelligence and personalized medicine Through analogies, insights, and fascinating facts, this episode highlights the meticulous processes behind the medications we rely on daily. Gain a new appreciation for the FDA's unseen but essential role in ensuring safety, efficacy, and quality across the complex and ever-evolving landscape of healthcare. Takeaway Thought: Next time you take a medication, remember the vast network of science, regulation, and oversight behind it, all driven by the FDA’s unwavering commitment to public health. Stay curious and keep exploring!

NOW PLAYING

30 Day FDA and ICH Drug Development Regulations - Day 2 FDA Overview

0:00 15:28

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 15 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 28, 2025.

What is this episode about?

In today’s episode, we continue our exploration into the intricate world of drug development, this time focusing on the pivotal role of the U.S. Food and Drug Administration (FDA). From preclinical research to post-market surveillance, we unpack how...

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!